Anzeige
❌
Mehr »
Mittwoch, 04.11.2026 - Börsentäglich über 12.000 News
Zehn Katalysatoren in vier Monaten und die Rally könnte erst beginnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
IB

WKN: 914998 | ISIN: BE0003766806 | Ticker-Symbol: IOB
Tradegate
03.11.26 | 21:54
16,100 Euro
+0,12 % +0,020
Branche
Sonstige Technologie
Aktienmarkt
BEL Mid
1-Jahres-Chart
ION BEAM APPLICATIONS SA Chart 1 Jahr
5-Tage-Chart
ION BEAM APPLICATIONS SA 5-Tage-Chart
RealtimeGeldBriefZeit
16,22016,36011:41
16,22016,28011:29

Aktuelle News zur ION BEAM APPLICATIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLaufende Fusionskontrollverfahren: Framatome SAS, Courbevoie (FR); Ion Beam Applications SA, Louvain-la-Neuve (BE); Gründung eines GU zur Herstellung des Radioisotops Astat-211: Ekalia SAS, Courbevoie (FR)341Datum der Anmeldung:30.10.2026Aktenzeichen:B3-115/26Unternehmen:Framatome SAS, Courbevoie (FR); Ion Beam Applications SA, Louvain-la-Neuve (BE); Gründung eines GU zur Herstellung des Radioisotops Astat-211:...
► Artikel lesen
ION BEAM APPLICATIONS Aktie jetzt für 0€ handeln
23.10.IBA SA: IBA signs major contract for a high-throughput Be Efficient sterilization solution in Germany21
19.10.IBA SA: Ekalia takes an important step in the deployment of Astatine-211 in the United States through a collaboration agreement with Telix5
19.10.IBA SA: IBA launches NEPTIS Perform Duo, one synthesizer module from tracer development to routine production3
19.10.XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.202612.074Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen. 1. US88025U1097 10X GENOMICS INC 2. NL0000852564 AALBERTS NV 3. SE0016589188 ELECTROLUX AB 4. SE0000115446...
► Artikel lesen
16.10.IBA SA: IBA and Framatome join forces to industrialize Astatine-211 production for cancer therapies8
15.10.IBA SA: IBA selected to support the US expansion of a leading radiopharmaceutical producer with an order for 12 Cyclone KIUBE systems11
01.10.IBA SA: IBA and Telix strengthen ties through agreement to distribute ARTMS's QIS450IBA to offer QUANTM Irradiation System solid-target technology to cyclotron users worldwide, scaling local production of radiometals for theranostics Louvain-la-Neuve, Belgium - October 1st, 2026...
► Artikel lesen
29.09.IBA SA: IBA signs contract to install the first proton therapy center in central Italy, in Rome501Louvain-La-Neuve, Belgium, September 29, 2026 at 7 a.m. CEST - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of...
► Artikel lesen
28.09.IBA SA: Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide404New expert-led services platform will help healthcare providers develop, implement, and optimize proton therapy and advanced radiation oncology programs across the full care delivery lifecycle PHILADELPHIA...
► Artikel lesen
27.09.IBA SA: IBA Launches QUASAR Penta-Guide Performance Phantom3
25.09.IBA SA: IBA to coordinate LIFEDESTINY, a new European LIFE project to advance sustainable PFAS remediation5
02.09.IBA SA: IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications464Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m. - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS...
► Artikel lesen
27.08.IBA H1 2026 slides: proton therapy drives 66% EBIT jump33
27.08.IBA SA: IBA reports Half Year 2026 results, on track with its improved profitability trajectory667Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance...
► Artikel lesen
14.07.IBA SA: IBA - Regulated information36
30.06.IBA SA: The National Proton Therapy Center of Portugal will be equipped with two IBA ProteusONE solutions25
25.06.IBA SA: IBA to install the first proton therapy center in Brazil in Rio de Janeiro1.222Louvain-La-Neuve, Belgium, June 25, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions...
► Artikel lesen
17.06.Ion Beam Applications: Aktie legt nach Managementumbau um 7 % zu42
17.06.IBA SA: IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend24
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1